Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Guangzhou Medical UniversityActive in the last 2 years

Bin Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2184-4723; OpenAlex author ID A5100395574. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. BNC2 as a novel driver of pancreatic cancer progression through transcriptional regulation of COL3A1 and epithelial-to-mesenchymal transition. Last author DOI 10.1007/s12032-025-03139-9↗
  2. Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy. Co-author DOI 10.1016/j.phymed.2022.154406↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shunfang Liu · 1 shared paper, 2025 · strength 0.26
  2. Xiuming Li · 1 shared paper, 2025 · strength 0.26
  3. Dan Wang · 1 shared paper, 2025 · strength 0.26
  4. Zhu Zhang · 1 shared paper, 2022 · strength 0.17
  5. Joshua Ka-Shun Ko · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.